Are the Pieces Starting to Come Together for Management of Desmoid Tumors?
Anna C Greene1, Brian A Van Tine2,3,4
1Desmoid Tumor Research Foundation, Suffern, New York.
Abstract:
Desmoid tumor research is changing how desmoid tumors are managed with the prospective documentation that growing desmoid tumors spontaneously regress one third of the time. Patient partnership through the Desmoid Research Tumor Foundation and academia is leading to rapid advancement in desmoid tumor biology understanding and treatment. See related articles by Colombo et al., p. 4027, Nathenson et al., p. 4092, and Penel et al., p. 4105.
Insights
Growing desmoid tumors spontaneously regress one third of the time, changing management strategies. Patient partnerships accelerate understanding and treatment of these rare tumors.
Area of Science:
- Oncology
- Rare Diseases
- Tumor Biology
Background:
- Desmoid tumors are rare, aggressive fibromatoses with unpredictable behavior.
- Recent research highlights a significant rate of spontaneous regression in growing desmoid tumors.
Discussion:
- Prospective documentation confirms spontaneous regression occurs in approximately one-third of desmoid tumor cases.
- This finding challenges traditional management paradigms emphasizing immediate intervention.
Key Insights:
- Patient advocacy, exemplified by the Desmoid Research Tumor Foundation, is crucial for driving research progress.
- Collaborative efforts between patients and academic institutions are accelerating the understanding of desmoid tumor biology.
Outlook:
- Further research will refine risk stratification for active surveillance versus intervention.
- Enhanced understanding of desmoid tumor mechanisms may lead to novel targeted therapies.
